These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8661397)

  • 61. Vpu-induced degradation of CD4: requirement for specific amino acid residues in the cytoplasmic domain of CD4.
    Lenburg ME; Landau NR
    J Virol; 1993 Dec; 67(12):7238-45. PubMed ID: 8230446
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The human immunodeficiency virus type 1 Vpu protein: a potential regulator of proteolysis and protein transport in the mammalian secretory pathway.
    Vincent MJ; Abdul Jabbar M
    Virology; 1995 Nov; 213(2):639-49. PubMed ID: 7491787
    [TBL] [Abstract][Full Text] [Related]  

  • 63. HLA-DR peptide inhibits HIV-induced syncytia.
    Lewis DE; Ulrich RG; Atassi H; Atassi MZ
    Immunol Lett; 1990 May; 24(2):127-31. PubMed ID: 2191918
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Folding of HIV-1 envelope glycoprotein involves extensive isomerization of disulfide bonds and conformation-dependent leader peptide cleavage.
    Land A; Zonneveld D; Braakman I
    FASEB J; 2003 Jun; 17(9):1058-67. PubMed ID: 12773488
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Anchor sequence-dependent endogenous processing of human immunodeficiency virus 1 envelope glycoprotein gp160 for CD4+ T cell recognition.
    Polydefkis M; Koenig S; Flexner C; Obah E; Gebo K; Chakrabarti S; Earl PL; Moss B; Siliciano RF
    J Exp Med; 1990 Mar; 171(3):875-87. PubMed ID: 1968506
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effects of calcium ions on proteolytic processing of HIV-1 gp160 precursor and on cell fusion.
    Moulard M; Montagnier L; Bahraoui E
    FEBS Lett; 1994 Feb; 338(3):281-4. PubMed ID: 8307195
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The carboxy terminus of human immunodeficiency virus type 1 gp160 limits its proteolytic processing and transport in transfected cell lines.
    Haffar OK; Nakamura GR; Berman PW
    J Virol; 1990 Jun; 64(6):3100-3. PubMed ID: 2186180
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Receptor interference mediated by the envelope glycoproteins of various HIV-1 and HIV-2 isolates.
    Martin RA; Nayak DP
    Virus Res; 1996 Dec; 45(2):135-45. PubMed ID: 8896248
    [TBL] [Abstract][Full Text] [Related]  

  • 69. gp160 of HIV-I synthesized by persistently infected Molt-3 cells is terminally glycosylated: evidence that cleavage of gp160 occurs subsequent to oligosaccharide processing.
    Merkle RK; Helland DE; Welles JL; Shilatifard A; Haseltine WA; Cummings RD
    Arch Biochem Biophys; 1991 Oct; 290(1):248-57. PubMed ID: 1898096
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Identification of two sequences in the cytoplasmic tail of the human immunodeficiency virus type 1 envelope glycoprotein that inhibit cell surface expression.
    Bültmann A; Muranyi W; Seed B; Haas J
    J Virol; 2001 Jun; 75(11):5263-76. PubMed ID: 11333908
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Simple methods for monitoring HIV-1 and HIV-2 gp120 binding to soluble CD4 by enzyme-linked immunosorbent assay: HIV-2 has a 25-fold lower affinity than HIV-1 for soluble CD4.
    Moore JP
    AIDS; 1990 Apr; 4(4):297-305. PubMed ID: 2190604
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A monoclonal antibody directed to sulfatide inhibits the binding of human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein to macrophages but not their infection by the virus.
    Seddiki N; Ramdani A; Saffar L; Portoukalian J; Gluckman JC; Gattegno L
    Biochim Biophys Acta; 1994 Feb; 1225(3):289-96. PubMed ID: 8312376
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Transglutaminase covalently incorporates amines into human immunodeficiency virus envelope glycoprotein gp120 in vitro.
    Mariniello L; Esposito C; Gentile V; Porta R
    Int J Pept Protein Res; 1993 Aug; 42(2):204-6. PubMed ID: 8104907
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Glycosylation and stability of mature HIV envelope glycoprotein conformation under various conditions.
    Papandreou MJ; Idziorek T; Miquelis R; Fenouillet E
    FEBS Lett; 1996 Jan; 379(2):171-6. PubMed ID: 8635586
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Processing protease for gp160 human immunodeficiency virus type I envelope glycoprotein precursor in human T4+ lymphocytes. Purification and characterization.
    Kido H; Kamoshita K; Fukutomi A; Katunuma N
    J Biol Chem; 1993 Jun; 268(18):13406-13. PubMed ID: 8099909
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Oscillation of the human immunodeficiency virus surface receptor is regulated by the state of viral activation in a CD4+ cell model of chronic infection.
    Butera ST; Perez VL; Wu BY; Nabel GJ; Folks TM
    J Virol; 1991 Sep; 65(9):4645-53. PubMed ID: 1678437
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Posttranslational modifications within the HIV-1 envelope glycoprotein which restrict virus assembly and CD4-dependent infection.
    Haggerty S; Dempsey MP; Bukrinsky MI; Guo L; Stevenson M
    AIDS Res Hum Retroviruses; 1991 Jun; 7(6):501-10. PubMed ID: 1931229
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Calreticulin interacts with newly synthesized human immunodeficiency virus type 1 envelope glycoprotein, suggesting a chaperone function similar to that of calnexin.
    Otteken A; Moss B
    J Biol Chem; 1996 Jan; 271(1):97-103. PubMed ID: 8550632
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Apoptosis induced in CD4+ cells expressing gp160 of human immunodeficiency virus type 1.
    Lu YY; Koga Y; Tanaka K; Sasaki M; Kimura G; Nomoto K
    J Virol; 1994 Jan; 68(1):390-9. PubMed ID: 7504739
    [TBL] [Abstract][Full Text] [Related]  

  • 80. In vitro binding and internalization of HIV envelope glycoproteins by human epidermal Langerhans cells does not require the CD4-gp120-binding site.
    Schmitt D; Dezutter-Dambuyant C; Hanau D; Kolbe HV; Kieny MP; Cazenave JP; Thivolet J
    Res Virol; 1990; 141(2):209-15. PubMed ID: 1693220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.